title: Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man.
abstract: Nifedipine has been proven to be effective and safe in the treatment of primary oesophageal motility disorders which can cause angina-like chest pain and/or dysphagia. The effects of the calcium channel blockers nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal smooth muscle function in healthy male volunteers were studied by oesophageal manometry using the rapid pull-through-technique, in two randomized, double-blind crossover studies. Lower oesophageal sphincter pressure, oesophageal contraction amplitude and duration after a wet swallow (measured 5 cm and 10 cm above the lower oesophageal sphincter) were determined 30 min before and at 10 minute intervals up to 90 min after the administration of nimodipine and up to 120 min after nifedipine, nitrendipine and nisoldipine. The plasma drug concentration was measured at baseline (-15 min) and in parallel with the manometric measurements. Compared to placebo, lower oesophageal sphincter pressure was significantly decreased by 24% by nifedipine and 17% by nimodipine, whereas the effects of nitrendipine (decrease of 15%) and nisoldipine (9%) were not significant. Nifedipine significantly decreased by 17% the oral contraction amplitude compared to placebo and nimodipine by 11%. The duration of the contraction amplitudes was not altered. The decrease in sphincter pressure was correlated with the corresponding plasma drug levels of nifedipine r = 0.92, nitrendipine r = 0.80 and nisoldipine r = 0.79. Nimodipine showed no such correlation.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institute of Clinical Pharmacology, Bayer AG, Wuppertal, FRG.
authors.forename: I
authors.initials: I
authors.lastname: Konrad-Dalhoff
authors.forename: A R
authors.initials: AR
authors.lastname: Baunack
authors.forename: K D
authors.initials: KD
authors.lastname: Rämsch
authors.forename: G
authors.initials: G
authors.lastname: Ahr
authors.forename: H
authors.initials: H
authors.lastname: Kraft
authors.forename: H
authors.initials: H
authors.lastname: Schmitz
authors.forename: T R
authors.initials: TR
authors.lastname: Weihrauch
authors.forename: J
authors.initials: J
authors.lastname: Kuhlmann
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000494:pharmacology*; D004311:Double-Blind Method; D004943:Esophagogastric Junction / Q000187:drug effects / Q000502:physiology; D004947:Esophagus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D009543:Nifedipine / Q000494:pharmacology; D009553:Nimodipine / Q000494:pharmacology; D015737:Nisoldipine / Q000494:pharmacology; D009568:Nitrendipine / Q000494:pharmacology; D010528:Peristalsis; D011312:Pressure
chemical_list: D002121:Calcium Channel Blockers; D015737:Nisoldipine; D009553:Nimodipine; D009568:Nitrendipine; D009543:Nifedipine